Get Breaking Alerts on Stocks Before The Mainstream Media

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We guarantee you to keep your privacy
Connect with us
Financial Press
:-european-regulator-to-probe-whether-russians-were-forced-to-participate-in-sputnik-vaccine-trials:-report
:-european-regulator-to-probe-whether-russians-were-forced-to-participate-in-sputnik-vaccine-trials:-report

Breaking

: European regulator to probe whether Russians were forced to participate in Sputnik vaccine trials: report

Health regulators in Europe are set to investigate whether volunteers participating in Russia’s Sputnik V vaccine trials were pressured to take part, according to reports.

The European Medicines Agency (EMA) is already evaluating whether Sputnik V can be used in Europe and it is also expected to investigate whether the vaccine trial adhered to accepted international standards known as “Good Clinical Practice” (GCP).

It comes after text messages were published in December that newswire Reuters said was from the manager of a state office in Moscow pressuring his staff to sign up for the trials.

Read: Vaccine diplomacy: Putin seeks to leverage Sputnik V to build Russia’s global influence

Staff had been accused of signing up for flu shots which precluded them from being injected with the trial vaccine. The manager Sergei Martyanov is alleged to have texted: ‘Colleagues!!!… What is this sabotage???,’

‘Who are you trying to trick??? The coronavirus vaccine is the absolute priority!!!’ he allegedly wrote, asking staff to recruit friends and family.

Read: Russia registers ‘world’s first’ COVID-19 vaccine for dogs, cats and other animals

The EMA is expected to announce next week it will look into whether the Sputnik trials were conducted ethically, according to a report in the Financial Times newspaper, which said participants comprised of state employees and servicemen. The trial was part funded by the Kremlin’s Russian Direct Investment Fund (RDIF)

The boss of the RDIF Kirill Dmitriev, told the newspaper the EMA inspection was scheduled to begin next week adding: “There was no pressure [on participants] and Sputnik V complied with all clinical practices”.

The EMA said: “While the evaluation of Sputnik V vaccine is ongoing we cannot comment on planned or ongoing inspections. The need for GCP inspection of the conduct of a clinical trial is considered on a case by case basis by EMA’s scientific Committee for Human Medicines, CHMP.”

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We are Spam free & Secure 🙂

Other vaccines being used around the world include ones developed by AstraZeneca
AZN,
-1.17%
,
Moderna
MRNA,
-1.54%
,
Johnson & Johnson
JNJ,
+0.13%
,
Novavax
NVAX,
-3.91%
,
and Pfizer
PFE,
-0.39%

-BioNtech
BNTX,
-3.27%
.

Written By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Breaking

The Biden administration is expected to announce sanctions against Russian officials and entities for their alleged roles in election interference and the SolarWinds hack,...

Breaking

After years of being majority-owned by another company, VMware Inc. finally will separate from its parent — now Dell Technologies. But the deal will...

Breaking

The number of people who traveled the skies last year plummeted amid the coronavirus pandemic, but it appears that those who did opt to...

Breaking

European stocks edged higher in early action on Thursday, with equities resuming their upward march with bond yields under control. Up eight of the...

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address
We are Spam free & Secure :)

Get Breaking Stock Alerts

Email address

Get Breaking Stock Alerts

Stay informed of the biggest news on stocks so you can react before 90% of retail investors.
Email address